| Trial ID: | L4277 |
| Source ID: | NCT04080596
|
| Associated Drug: |
Dorzagliatin
|
| Title: |
DDI Study to Investigate the Impact of Itraconazole on the Pharmacokinetics of Dorzagliatin
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Drug Interaction
|
| Interventions: |
DRUG: Dorzagliatin
|
| Outcome Measures: |
Primary: Cmax, Peak concentration, up to 96 hours|AUClast, Area under the curve, up to 96 hours |
|
| Sponsor/Collaborators: |
Sponsor: Hua Medicine Limited
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
18
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: |Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2017-10-13
|
| Completion Date: |
2017-12-05
|
| Results First Posted: |
|
| Last Update Posted: |
2019-09-06
|
| Locations: |
The 2nd Hospital of Jilin University, Changchun, Jilin, 130021, China
|
| URL: |
https://clinicaltrials.gov/show/NCT04080596
|
